Literature DB >> 9444383

Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis.

J Chan1, B R Smoller, S P Raychauduri, W Y Jiang, E M Farber.   

Abstract

In order to evaluate more fully the role of neuropeptides in the pathogenesis of psoriasis, skin biopsies were obtained from 36 patients with psoriasis to identify substance P (SP), vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP). Lesional and nonlesional skin was examined from these biopsies and the results compared with those from biopsies taken from patients with a variety of other inflammatory dermatoses, including lichen planus, lichen simplex chronicus, spongiotic dermatitis, and seborrheic dermatitis. Also studied was a series of nine biopsies taken from patients with no known skin disorders. We found an increase in the number of SP-positive nerve fibers within the epidermis in biopsies from lesional skin of psoriasis patients (8.4 nerves per 3-mm biopsy) compared with nonlesional psoriatic skin (2.6 nerves per 3-mm biopsy) and normal skin (2.0 nerves per 3 mm biopsy). Other inflammatory disorders also demonstrated fewer SP-positive nerves than lesional psoriatic skin; lichen planus (0 nerves per 3 mm biopsy) and lichen simplex chronicus (1.3 nerves per 3 mm biopsy). The difference in SP-positive nerve expression between lesional psoriatic skin and the group comprising nonlesional skin, normal skin, lichen planus, and lichen simplex chronicus attained statistical significance (P < 0.013). SP-positive intraepidermal nerve fibers in lesional psoriatic specimens were fewer than in spongiotic dermatitis (17.4 nerves per 3 mm biopsy). There was no significant difference in numbers of VIP- or CGRP-immunopositive intraepidermal nerve fibers between psoriatic skin and the group comprising all other material tested. However, in five patients with psoriasis, there was a marked increase in the expression of intraepidermal CGRP (up to 10.7 nerves per 3-mm biopsy) and VIP (up to 8.3 nerves per 3-mm biopsy) which was not observed in control groups. These findings suggest that neuropeptides SP, CGRP, and VIP play a role in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444383     DOI: 10.1007/s004030050249

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases.

Authors:  Sherrie J Divito; Adrian E Morelli; Adriana T Larregina
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

3.  Visual evoked potentials in patients with psoriasis vulgaris.

Authors:  A Grzybowski; G Grzybowski; A Druzdz; R Zaba
Journal:  Doc Ophthalmol       Date:  2001-11       Impact factor: 2.379

4.  Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin.

Authors:  K Sauerstein; M Klede; M Hilliges; M Schmelz
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

Review 5.  Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.

Authors:  Ferda Cevikbas; Martin Steinhoff; Akihiko Ikoma
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

6.  Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis.

Authors:  Siba P Raychaudhuri; Wen-Yue Jiang; Smriti K Raychaudhuri
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

7.  Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases.

Authors:  Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

8.  [Pruritus in psoriasis : Profile and therapy].

Authors:  A Tsianakas; U Mrowietz
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

9.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 10.  Gabapentinoids for Pruritus in Older Adults: A Narrative Review.

Authors:  Shreya A Sreekantaswamy; Nicholas Mollanazar; Daniel C Butler
Journal:  Dermatol Ther (Heidelb)       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.